An Observational Real-Life Study with a New Infant Formula in Infants with Functional Gastro-Intestinal Disorders

Yvan Vandenplas1, Laetitia Gerlier2, Karin Caekelbergh2

  • 1KidZ Health Castle, Vrije Universiteit Brussel (VUB), UZ Brussel, 1090 Brussels, Belgium.

Nutrients
|October 23, 2021
PubMed

Insights

A specialized infant formula significantly reduced functional gastro-intestinal disorders (FGIDs) and improved quality of life within days. This nutritional intervention offers effective relief for infants experiencing FGIDs.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Nutritional Science

Background:

  • Functional gastro-intestinal disorders (FGIDs) significantly impact infant and family well-being.
  • Existing management strategies for FGIDs in infants often require improvement.

Purpose of the Study:

  • To evaluate the efficacy of a specialized infant formula in managing FGIDs.
  • To assess the impact of the formula on infant quality of life.

Main Methods:

  • A two-week intervention with a formula containing partial whey hydrolysate, starch, magnesium, prebiotics (FOS/GOS), and probiotic *Lactobacillus reuteri* DSM 17938.
  • 196 infants with at least two FGIDs were enrolled.
  • Efficacy measured by Cow Milk-associated Symptom Score (CoMiSS) and quality of life by QUALIN score.

Main Results:

  • Significant reduction in FGIDs within three days (CoMiSS decrease: -1.29, p < 0.0001).
  • Improved infant quality of life observed after seven days (QUALIN increase: +1.4, p = 0.008).
  • Constipation incidence decreased from 18.8% to 6.5% within three days.

Conclusions:

  • The specialized infant formula effectively alleviates FGIDs and enhances quality of life.
  • This nutritional approach, combined with guidance, proves beneficial in real-world infant care settings.
  • Early intervention with targeted nutrition can positively influence infant gastro-intestinal health.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
451
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
337
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
659
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
383
Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
189
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
544